製薬業界は,毎年何百万人もを救うことを目指す,非暴力の病気と闘うための世界協力を要請する. Pharmaceutical industry calls for global cooperation to combat non-communicable diseases, aiming to save millions annually.

世界の医薬産業は,世界人口の75%を占める非抗生物質の増加問題(NCDs)に対処するよう国際協力を促している. The global pharmaceutical industry is urging international cooperation to tackle the growing issue of non-communicable diseases (NCDs), which cause 75% of global deaths. 公的医療費の増加を主張し,特にNCDを対象に,低所得国や中所得国における年間約500万人の命を救うことができる. They advocate for increased public healthcare spending, specifically targeting NCDs, which could save about 5 million lives annually in low- and middle-income countries. 業界はNCDに対する認可された1400以上の医薬品を強調し,NCDに関する国連会議の前にイノベーション,投資,説明責任の促進を呼びかけています. The industry highlights over 1,400 approved medicines for NCDs and calls for enabling innovation, investment, and accountability ahead of a UN meeting on NCDs.